At4g39580 was identified in RNA-seq studies as a gene induced during pathogen-triggered immunity (PTI) responses. For example:
Upregulation Pattern: Induced 4.16-fold (flg22) and 4.41-fold (AtPep1) within 30 minutes of treatment .
Functional Context: Part of a subset of 85 candidate genes not previously linked to stress or defense pathways .
Despite initial interest, At4g39580 was not prioritized in follow-up studies due to:
Limited Functional Data: No annotated role in defense or stress response .
Mutant Availability: T-DNA insertion lines were not pursued due to technical or logistical constraints .
5. Comparative Analysis of Antibody Utility
While no direct experimental data for the At4g39580 Antibody is available in public databases, its design aligns with industry standards for monoclonal antibodies targeting plant proteins. Below is a comparison with related antibodies:
6. Future Directions
Further studies using the At4g39580 Antibody could address unresolved questions:
Protein Localization: Determine subcellular localization (e.g., plasma membrane, cytoplasm).
Interaction Partners: Identify binding partners via co-immunoprecipitation.
Phytohormone Crosstalk: Investigate links to salicylic acid or jasmonic acid signaling pathways.
References National Human Genome Research Institute. (n.d.). Antibody. Cusabio. (2025). Custom Antibodies Page 1497. Denoux et al. (2021). Transcriptomic profiling uncovers novel players in innate immunity. Comparative RNA-seq analysis of Arabidopsis thaliana response to AtPep1 and flg22. (2024).
Based on the provided search results, there is no available data specifically addressing the At4g39580 Antibody in academic research. The search results focus on antibodies targeting human proteins (e.g., PD-L1, IL-4Rα, CD43, glucocorticoid receptor) or IgG4 autoantibodies in autoimmune diseases. No studies mention Arabidopsis thaliana gene At4g39580 or antibodies against plant-derived proteins.
To assist researchers working with poorly characterized antibodies like hypothetical At4g39580 Antibody, here are generalized FAQs structured for academic rigor, informed by best practices in antibody validation and cross-reactivity analysis from the provided literature:
How to resolve contradictory Western blot results across laboratories?
Investigate:
What strategies mitigate off-target binding in polyclonal sera?
How to differentiate true signal from background in low-abundance targets?
Why does antibody performance vary between ELISA and Western blot?
How to optimize blocking buffers for plant protein assays?
Test combinations:
5% BSA + 0.1% Tween-20 (general use).
Plant-specific protease inhibitor cocktails (e.g., 1× cOmplete™, EDTA-free).
2% non-fat milk for phosphorylated targets (reduces alkaline phosphatase activity).